Cargando…

ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR BIOSIMILARS IN OPHTHALMOLOGY

Anti–vascular endothelial growth factor therapies have proven effective in treating retinal diseases but come with a high financial burden to the patient and health care system. Biosimilar drugs present an opportunity to decrease the cost of these important ophthalmic medications, and several ophtha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaiser, Peter K., Schmitz-Valckenberg, Marc Steffen, Holz, Frank G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Retina 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665947/ https://www.ncbi.nlm.nih.gov/pubmed/36394884 http://dx.doi.org/10.1097/IAE.0000000000003626

Ejemplares similares

Imaging of Therapeutic Effects of Anti-Vascular Endothelial Growth Factor Inhibitors by Optical Coherence Tomography Angiography in a Rat Model
por: Meyer, Johanna H., et al.
Publicado: (2020)

Anti-vascular endothelial growth factor in ophthalmology
por: Sinha, Rajesh, et al.
Publicado: (2009)

The era of anti-vascular endothelial growth factor (VEGF) drugs in ophthalmology, VEGF and anti-VEGF therapy
por: Pożarowska, Dorota, et al.
Publicado: (2016)

Quantifying the increasing use of anti-vascular endothelial growth factor therapy in ophthalmology
por: Micieli, Jonathan A., et al.
Publicado: (2011)

Re: Trivizki et al. Local Geographic Atrophy Growth Rates Not Influenced by Close Proximity to Non-Exudative Type 1 Macular Neovascularization
por: Pfau, Maximilian, et al.
Publicado: (2022)

Changing trends in the use of anti-vascular endothelial growth factor (anti-VEGF) biosimilars: Insights from the Vitreoretinal Society of India Biosimilars of Anti-VEGF Survey
por: Sheth, Jay U, et al.
Publicado: (2021)

Biosimilars in ophthalmology: “Is there a big change on the horizon?”
por: Sharma, Ashish, et al.
Publicado: (2018)

Commentary: Anti-vascular endothelial growth factor therapies in vitreo-retina practice: Biosimilars versus biologics
por: Anantharaman, Giridhar
Publicado: (2021)

All India Ophthalmological Society members' survey: Practice pattern of intravitreal anti-vascular endothelial growth factor injection
por: Sundar, Dheepak, et al.
Publicado: (2020)

Anti-Vascular Endothelial Growth Factor Therapy in Breast Cancer
por: Kristensen, Tina Bøgelund, et al.
Publicado: (2014)

Commentary: All India Ophthalmological Society members' survey: Practice pattern of intravitreal anti-vascular endothelial growth factor injection
por: Gopal, Lingam, et al.
Publicado: (2020)

Commentary: All India Ophthalmological Society members' survey: Practice pattern of intravitreal anti-vascular endothelial growth factor injection
por: Anantharaman, Giridhar
Publicado: (2020)

Early Vitrectomy with Silicone Oil Tamponade in the Management of Postoperative Endophthalmitis
por: Weber, Constance, et al.
Publicado: (2023)

Intravitreal Anti-Vascular Endothelial Growth Factor Therapies for Retinal Disorders
por: Hang, Abraham, et al.
Publicado: (2023)

Algorithms for the Automated Analysis of Age-Related Macular Degeneration Biomarkers on Optical Coherence Tomography: A Systematic Review
por: Wintergerst, Maximilian W.M., et al.
Publicado: (2017)

Vascular endothelial growth factors and vascular permeability
por: Bates, David O.
Publicado: (2010)

The Role of Focal Laser in the Anti–Vascular Endothelial Growth Factor Era
por: Crosson, Jason N, et al.
Publicado: (2017)

Anti-vascular endothelial growth factor therapy for the treatment of myopic choroidal neovascularization
por: Tan, Colin S, et al.
Publicado: (2017)

The role of anti-vascular endothelial growth factor (anti-VEGF) in the management of proliferative diabetic retinopathy
por: Zhao, Yue, et al.
Publicado: (2018)

Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration
por: Holz, Frank G, et al.
Publicado: (2015)

Biomarkers for anti-vascular endothelial growth factor drugs
por: Kuriyama, Sho, et al.
Publicado: (2022)

Vascular emergencies in neuro-ophthalmology
por: Iorga, Eugenia Raluca, et al.
Publicado: (2020)

Evolution of the EU Biosimilar Framework: Past and Future
por: Wolff-Holz, Elena, et al.
Publicado: (2019)

Anti-vascular endothelial growth factor drugs safety and efficacy in ophthalmic diseases
por: Ventrice, Pasquale, et al.
Publicado: (2013)

Vascular Endothelial Growth Factor, a Key Modulator of the Anti-Tumor Immune Response
por: Geindreau, Mannon, et al.
Publicado: (2021)

Evaluation of Two Systems for Fundus-Controlled Scotopic and Mesopic Perimetry in Eye with Age-Related Macular Degeneration
por: Steinberg, Julia S., et al.
Publicado: (2017)

Association of complement C3 inhibitor pegcetacoplan with reduced photoreceptor degeneration beyond areas of geographic atrophy
por: Pfau, Maximilian, et al.
Publicado: (2022)

AI-based structure-function correlation in age-related macular degeneration
por: von der Emde, Leon, et al.
Publicado: (2021)

The role of vascular endothelial growth factor in ossification
por: Yang, Yan-Qi, et al.
Publicado: (2012)

Immunosuppressive effects of vascular endothelial growth factor
por: Ribatti, Domenico
Publicado: (2022)

Anti-Vascular Endothelial Growth Factor Agents for Ocular Angiogenesis and Vascular Permeability
por: Kubota, Toshiaki, et al.
Publicado: (2012)

Preparing for the incoming wave of biosimilars in oncology
por: Wolff-Holz, Elena, et al.
Publicado: (2018)

Inhibition of Vascular Growth by Modulation of the Anandamide/Fatty Acid Amide Hydrolase Axis
por: Rieck, Sarah, et al.
Publicado: (2021)

Debate on the various anti-vascular endothelial growth factor drugs
por: Khalili, Mohammad Reza, et al.
Publicado: (2008)

Future of anti-VEGF: biosimilars and biobetters
por: Kapur, Monika, et al.
Publicado: (2022)

Longitudinal Analysis of Structural and Functional Changes in Presence of Reticular Pseudodrusen Associated With Age-Related Macular Degeneration
por: Sassmannshausen, Marlene, et al.
Publicado: (2020)

Prognostic value of intermediate age-related macular degeneration phenotypes for geographic atrophy progression
por: Thiele, Sarah, et al.
Publicado: (2021)

Vascular endothelial growth factor‐C in activating vascular endothelial growth factor receptor‐3 and chemokine receptor‐4 in melanoma adhesion
por: Hlophe, Yvette N., et al.
Publicado: (2022)

MANAGEMENT OF RETINAL PIGMENT EPITHELIUM TEAR DURING ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY
por: Mitchell, Paul, et al.
Publicado: (2021)

Role of hypoxia and vascular endothelial growth factors in lymphangiogenesis
por: Morfoisse, Florent, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_iavrd14foraj8576ivqr2ce0ot